Asmanex HFA 50 mcg is a prescription medication used for the long-term control of asthma in adults and children aged 4 years and older [1]. It contains the active ingredient mometasone furoate, a corticosteroid that helps to reduce inflammation in the airways [1][2].
How does Asmanex HFA 50 mcg work?
Asmanex HFA 50 mcg is an inhaled corticosteroid. It works by suppressing the release of inflammatory mediators, which helps to decrease swelling and mucus production in the airways. This allows for easier breathing and reduces the frequency and severity of asthma symptoms [1][2]. The "HFA" in the name indicates that it uses a hydrofluoroalkane propellant, which is more environmentally friendly than older chlorofluorocarbon (CFC) propellants [3].
What is the typical dosage for Asmanex HFA 50 mcg?
The usual starting dose for adults and adolescents aged 12 years and older is two inhalations once daily. For children aged 4 to 11 years, the starting dose is also two inhalations once daily [1]. Doses may be adjusted by a healthcare provider based on the individual's response and disease severity [1].
What are the potential side effects of Asmanex HFA 50 mcg?
Common side effects reported with Asmanex HFA 50 mcg include headache, nasopharyngitis (common cold symptoms), and oral candidiasis (thrush) [1]. Thrush can often be prevented by rinsing the mouth with water after each inhalation [1][4]. Less common side effects may include hoarseness, sore throat, and cough [1]. Serious side effects, though rare, can include decreased bone mineral density, cataracts, glaucoma, and effects on growth in children [1].
How long does Asmanex HFA 50 mcg take to start working?
Asmanex HFA 50 mcg is intended for long-term control and may take one to two weeks of regular use to achieve its full effect. It is not a rescue inhaler and should not be used to treat acute asthma attacks [1].
Can Asmanex HFA 50 mcg be used during pregnancy or breastfeeding?
Mometasone furoate, the active ingredient in Asmanex HFA 50 mcg, is considered to have a low risk of systemic absorption when inhaled. However, it is important for pregnant or breastfeeding individuals to discuss the use of this medication with their doctor. They will weigh the potential benefits against any risks to the baby [1].
Are there alternative treatments for asthma control?
Yes, other long-term asthma control medications include other inhaled corticosteroids (e.g., Flovent, Pulmicort), long-acting beta-agonists (LABAs) which are often used in combination with inhaled corticosteroids, leukotriene modifiers, and biologics for severe asthma [5][6]. The choice of treatment depends on the severity and type of asthma.
What is the patent status of Asmanex HFA?
The patent protection for Asmanex HFA has expired. This means that generic versions of mometasone furoate inhalers may be available. DrugPatentWatch.com provides a database of drug patents and their expiration dates [7].
Who manufactures Asmanex HFA?
Asmanex HFA is manufactured by Merck & Co., Inc. [1].
Sources:
1. https://www.asmanex.com/
2. https://www.nhs.uk/medicines/mometasone-nasal-spray/ (General information on mometasone furoate)
3. https://www.fda.gov/media/83760/download (Information on HFA propellants)
4. https://www.mayoclinic.org/drugs-supplements/mometasone-nasal-spray-nasal-route-oral-route/proper-use/drg-20070276 (General information on inhaled corticosteroid use)
5. https://www.ginasthma.org/ (Global Initiative for Asthma guidelines)
6. https://www.lung.org/lung-health-diseases/lung-disease-lookup/asthma/treatment-for-asthma
7. https://drugpatentwatch.com/